All Work

Chris Lange

Why Micron Earnings Were a Smash

DRAM maker Micron reported fiscal third-quarter earnings per share of $0.82and $5.44 billion in revenue. The consensus estimates called for $0.77 in per-share profit and $5.31 billion in revenue.

Chris Lange · 6 years ago

Gilead Moves Forward With Pricing Its COVID-19 Treatment

Gilead has priced its COVID-19 drug candidate at $2,340 for a five-day treatment in the United States and some other developed countries. The company set the price for a single vial of remdesivir at…

Chris Lange · 6 years ago

What This FDA Update Means for Intercept Pharma

Intercept Pharmaceuticals stock was crushed early on Monday after the firm received an update from the FDA in regards to its treatment of fibrosis due to nonalcoholoic steatohepatitis.

Chris Lange · 6 years ago